LGAISep 14, 2021

Deep Denerative Models for Drug Design and Response

arXiv:2109.06469v11 citations
Originality Synthesis-oriented
AI Analysis

This is an incremental review paper for researchers in computational drug discovery.

This review paper provides an overview of deep generative models for drug design and response prediction, summarizing current state-of-the-art approaches and limitations in the field.

Designing new chemical compounds with desired pharmaceutical properties is a challenging task and takes years of development and testing. Still, a majority of new drugs fail to prove efficient. Recent success of deep generative modeling holds promises of generation and optimization of new molecules. In this review paper, we provide an overview of the current generative models, and describe necessary biological and chemical terminology, including molecular representations needed to understand the field of drug design and drug response. We present commonly used chemical and biological databases, and tools for generative modeling. Finally, we summarize the current state of generative modeling for drug design and drug response prediction, highlighting the state-of-art approaches and limitations the field is currently facing.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes